Splenectomy for adult chronic idiopathic thrombocytopenic purpura: experience from a single center in China

Abstract

SE is potentially a useful therapy to provide long-term control of disease in adults with chronic ITP and is associated with low morbidity and mortality. Postsplenectomy peak platelet count, time from diagnosis to SE and previous response to intravenous immune globulin therapy appear predictive for response to SE.